Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
Product › Details

ASGCT Annual Meeting

Products Next higher product group conference, medicine/diagnostics
Organisation Organisation American Society of Gene and Cell Therapy (ASGCT)
     

Uniqure N.V.. (5/1/17). "Press Release: Uniqure Announces Company Presentations at Upcoming May Conferences". Lexington, MA & Amsterdam.

-- Investor breakfast event and webcast at ASGCT on Friday, May 12 at 7:00 a.m. EDT --


uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced company presentations at the following conferences taking place in May:


American Society of Gene and Cell Therapy (ASGCT), May 10 - 13 2017, at the Marriott Wardman Park hotel in Washington, D.C.

> Five abstracts have been accepted for presentation at the ASGCT meeting. Together with their collaborators, members of uniQure's research and development team will present data focused on progress in re-administration protocols, gene therapy delivery systems and optimized vector distribution technologies in two of uniQure's key programs, hemophilia-B and Huntington's disease.

> In addition, uniQure management will host an investor and analyst breakfast meeting & webcast featuring senior leaders of its research and development team. To request attendance at the meeting, taking place at May 12, 2017 at 7:00 a.m. EDT, please RSVP to Investors@uniQure.com by May 5, 2017, as space is limited.

> The live webcast can be accessed through the link displayed in the Investor section of the uniQure website at: http://uniqure.com/investors-newsroom/events-presentations.php. The webcast replay will be available for at least two weeks following the live event.


UBS Global Healthcare Conference, May 22 - 24 2017, at the Grand Hyatt New York, in New York City.

> Matthew Kapusta, chief executive officer, will present on Tuesday, May 23rd, 2017 at 3:00 p.m. EDT. The live webcast can be accessed through the link displayed in the Investor section of the uniQure website at: http://uniqure.com/investors-newsroom/events-presentations.php. The webcast replay will be available for at least two weeks following the live event.


American Biomanufacturing Summit, May 23 - 24 2017, at the Hyatt Regency Mission Bay Spa & Marina, in San Diego, California.

> Lance Weed, Vice President of US Operations, will be presenting: Developing a Scalable Disposable Manufacturing Facility for Producing Gene Therapies, on May 24 at 3:00 p.m. PT. uniQure's Lexington-based facility is one of the largest, most versatile gene therapy manufacturing facilities in the world, with state-of-the-art commercial-scale production capabilities that utilize 100% single-use components.


About uniQure

uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington's disease and cardiovascular diseases. www.uniQure.com.


uniQure Contacts:

Maria E. Cantor
Direct: 339-970-7536
Mobile: 617-680-9452
m.cantor@uniQure.com

Tom Malone
Direct: 339-970-7558
Mobile: 339-223-8541
t.malone@uniQure.com

Eva M. Mulder
Direct: +31 20 240 6103
Mobile: +31 6 52 33 15 79
e.mulder@uniQure.com

   
Record changed: 2019-03-17

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px
» Show all Events!


ASGCT Annual Meeting

Past & forthcoming events


To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our free web portals Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px




» top